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SUMMARY
Objective: To investigate unbalanced and balanced acrocentric rearrangements involving chromosomes other
than chromosome 21 at amniocentesis.
Materials and Methods: From January 1987 to September 2009, 31,194 amniocenteses were performed at
Mackay Memorial Hospital, Taipei, Taiwan. Two cases with unbalanced acrocentric rearrangements involving
chromosomes other than chromosome 21 from two families, and 24 cases with balanced acrocentric rearrange-
ments involving chromosomes other than chromosome 21 from 21 families were diagnosed and investigated.
Results: We detected i(13q13q), +13 (one case), rob(13q14q), +13 (one case), rob(13q14q) (16 cases),
rob(14q15q) (five cases), rob(13q15q) (one case), rob(15q22q) (one case), and mosaic rob(14q22q) (one
case). Of the 25 cases that underwent parental cytogenetic investigation, six arose de novo and 19 were inherited
(10 maternal and nine paternal). The 16 families with an inherited Robertsonian translocation included
rob(13q14q) (11 families), rob(14q15q) (four families), and rob(15q22q) (one family). Of these 16 families,
only two had known parental carrier status prior to the first amniocentesis, while the other 14 were aware of a
parental carrier status only after prenatal diagnosis of a fetus with a heterologous Robertsonian translocation.
The 18 fetuses with balanced heterologous Robertsonian translocations inherited them from six maternal carriers
of rob(13q14q), four paternal carriers of rob(13q14q), four paternal carriers of rob(14q15q), and one maternal
carrier of rob(15q22q). Neither UPD14 nor UPD15 was detected in any of the 16 cases tested for UPD.
Conclusion: Concerning acrocentric rearrangements involving chromosomes other than chromosome 21, we
found a frequency of 0.0064% for unbalanced rearrangements and 0.0769% for balanced rearrangements at
amniocentesis in this study. rob(13q14q) was the most common and rob(14q15q) the second most common
rearrangement. Of the families with an inherited translocation, 87.5% were aware of parental carrier status only
after prenatal diagnosis of a fetus with a translocation by amniocentesis. [Taiwan J Obstet Gynecol 2009;48(4):
389–399]
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Introduction
Trisomy 13 can occur as free trisomy 13 with a 
free extra chromosome 13 (as in 47,XY, +13 or 
47,XX, +13), as a Robertsonian translocation [such as
rob(13q13q), rob(13q14q), rob(13q15q), rob
(13q21q) or rob(13q22q) involving chromosome 13],
or as isochromosome i(13q). Trisomy 13 syndrome or
Patau syndrome is the third most common autosomal
chromosome trisomy after trisomy 21 and trisomy 18.
The incidence of mutant translocation trisomy 13 has
been estimated at 0.012 per 1,000 live births
(1/80,000) to 0.018 per 1,000 live births (1/56,000),
while the incidence of familial translocation trisomy 13
has been estimated to be 0.024 per 1,000 live births
(1/42,000) to 0.03 per 1,000 live births (1/33,000)
[1]. In a study of spontaneous abortions, Jacobs et al
[2] reported that 26% of trisomy 13 cases were translo-
cation trisomy 13. They also found that the most com-
mon Robertsonian translocation causing interchange
trisomy 13 was rob(13q14q) and that the most com-
mon translocation causing secondary trisomy 13 was
rea(13q;13q) in the form of either rob(13q13q) or
i(13q). The majority of cases of rea(13q13q) trisomy
13 have been identified as i(13q) following DNA poly-
morphism analysis [3]. Hook [4] found that the
mutant proportion was about 90% for rea(13q13q) 
trisomy 13 cases and about 45% for rob(13q14q) 
trisomy 13 cases. The prevalence of the rob(13q14q)
carrier is about 1 in 1,300, and the frequencies of
rob(13q13q), rob(13q14q), rob(13q15q), rob(13q21q)
and rob(13q22q) among all balanced Robertsonian
translocations have been estimated to be 2%, 74%, 2%,
1% and 2%, respectively, by unbiased ascertainment [5].
In cases of parental non-homologous Robertsonian
translocations, trisomy rescue may occur in an initially
trisomic zygote or monosomy rescue after fertilization
of a normal gamete by a nullisomic gamete, and such
trisomy or monosomy rescues can result in uniparental
disomy (UPD) from the parent that does not carry the
translocation [6]. In cases of de novo non-homologous
Robertsonian translocations, UPD from the parent
whose chromosomes are involved in the translocation
is also possible [6]. Maternal and paternal UPD14 and
UPD15 are syndromic, whereas maternal and paternal
UPD13, UPD21 and UPD22 have no apparent pheno-
typic effects [6,7]. Shaffer et al [8] suggested that UPD
testing should be considered, especially in cases with
prenatally identified Robertsonian translocations
involving chromosomes 14 and 15. Kotzot [6] sug-
gested that prenatal UPD testing was justified follow-
ing genetic counseling if paternal UPD14, maternal
UPD15 or paternal UPD15 were suspected. Maternal
UPD14 is characterized by short stature, muscular
hypotonia, precocious puberty, truncal obesity, and
variable psychomotor retardation [6,7]. Paternal
UPD14 is characterized by severe psychomotor retar-
dation, polyhydramnios, mild contractures of the fin-
gers, and bell-shaped thorax with a coat-hanger sign
[6,7]. Maternal UPD15 is associated with Prader-Willi
syndrome which is characterized by muscular hypoto-
nia, feeding difficulties in infancy followed by hyper-
phagia and subsequent obesity, moderate mental
retardation, hypogonadotropic hypogonadism, facial
dysmorphisms including almond-shaped eyes, and
short hands and feet [6,7]. Paternal UPD15 is associ-
ated with Angelman syndrome which is characterized
by severe mental retardation, ataxia, seizures, elec-
troencephalographic abnormalities, jerky movements,
and inappropriate laughter [6,7].
Fetuses with unbalanced or balanced acrocentric
rearrangements involving chromosomes other than
chromosome 21 may be associated with trisomy 13,
UPD14 and/or UPD15 in cases involving chromosomes
13, 14 and/or 15. Here, we present our experience 
of the prenatal diagnosis of unbalanced and balanced
acrocentric rearrangements involving chromosomes
other than chromosome 21 using amniocentesis.
Materials and Methods
From January 1987 to September 2009, 31,194 amnio-
centeses were performed at Mackay Memorial Hospital,
Taipei, Taiwan, because of advanced maternal age,
abnormal ultrasound findings, abnormal maternal serum
screening results, a previous child with a congenital
anomaly, a family history of chromosome aberrations
or for other reasons. Two cases with unbalanced acrocen-
tric rearrangements involving chromosomes other than
chromosome 21 from two families, and 24 cases with
balanced acrocentric rearrangements involving chromo-
somes other than chromosome 21 from 21 families were
diagnosed. Cytogenetic analysis of parental blood lym-
phocytes was performed in 22 families. Polymorphic
DNA markers were used to investigate UPD14 and/or
UPD15 in 16 cases. The clinical data of the 26 cases
from 23 families are summarized in the Table.
Results
In the 31,194 cases with amniocentesis, the frequency
of unbalanced acrocentric rearrangements involving
chromosomes other than chromosome 21 was
0.0064% (2/31,194), and the frequency of balanced
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acrocentric rearrangements involving chromosomes
other than chromosome 21 was 0.0769% (24/31,194).
In this study, we detected i(13q13q), +13 (one
case), rob(13q14q), +13 (one case), rob(13q14q) 
(16 cases), rob(14q15q) (five cases), rob(13q15q) 
(one case), rob(15q22q) (one case), and mosaic
rob(14q22q) (one case) (Figures 1–7). Of the 25 cases
with parental cytogenetic investigation, six arose de novo
and 19 were inherited (10 maternal and nine pater-
nal). The 16 families with an inherited Robertsonian
translocation included rob(13q14q) (11 families),
rob(14q15q) (four families), and rob(15q22q) (one
family). Among these 16 families, only two (Cases 5 and
13) had a known parental carrier status prior to the
first amniocentesis, while the other 14 were aware of
parental carrier status only after prenatal diagnosis of a
fetus with a heterologous Robertsonian translocation.
The 18 fetuses with balanced heterologous Robertsonian
translocations showed inheritance from six maternal
carriers of rob(13q14q), four paternal carriers of
rob(13q14q), four paternal carriers of rob(14q15q),
and one maternal carrier of rob(15q22q). Neither
UPD14 nor UPD15 was detected in any of the 16 cases
tested for UPD.
The two cases of trisomy 13 with unbalanced acro-
centric rearrangements (Cases 1 and 2) prenatally man-
ifested holoprosencephaly (HPE). The case of trisomy
13 associated with i(13)(q10) arose de novo. The other
case of trisomy 13 associated with rob(13q14q) was
inherited from a maternal carrier. The details of these
two cases are as follows.
Case 1
This was the first pregnancy of a 31-year-old, gravida 1,
para 0, woman who was referred for amniocentesis at
26 weeks’ gestation because of abnormal sonographic
findings of HPE, cebocephaly, and a ventricular septal
defect. Amniocentesis revealed a 46,XX, +13, der(13;13)
(q10;q10) karyotype. The parental karyotypes analyzed
from blood lymphocytes were normal. Polymorphic
DNA marker analysis showed that the rea(13q13q) was
isochromosome 13 and was of maternal origin [9]. The
karyotype was 46,XX,i(13)(q10). The pregnancy was
subsequently terminated, and a dysmorphic fetus with
cebocephaly and polydactyly was delivered. Her second
pregnancy resulted in a healthy daughter with a 46,XX
karyotype. Her third pregnancy resulted in a healthy boy
with a 46,XY karyotype.
Case 2
This was the fifth pregnancy of a 39-year-old, gravida
5, para 1, woman. She had experienced three abortions
and had a healthy 13-year-old boy. During her current
pregnancy, she underwent amniocentesis at 20 weeks’
gestation because of advanced maternal age, and the
result revealed a 46,XX, +13,der(13;14)(q10;q10) karyo-
type. The paternal karyotype was 46,XY. The maternal
karyotype was 45,XX,der(13;14)(q10;q10). Ultrasound
at 24 weeks’ gestation showed polydactyly, cebocephaly,
and intrauterine growth restriction [10]. The pregnancy
was subsequently terminated. The proband manifested
all the prenatally observed abnormalities.
Discussion
Concerning acrocentric rearrangements involving chro-
mosomes other than chromosome 21, we found fre-
quencies of 0.0064% for unbalanced rearrangements
and 0.0769% for balanced rearrangements among the
patients undergoing amniocentesis. In our study,
rob(13q14q) was the most common and rob(14q15q)
the second most common rearrangement. Of the fami-
lies with an inherited translocation, 87.5% (14/16)
were aware of parental carrier status only after prenatal
diagnosis of a fetus with a translocation. Our results
show that unbalanced acrocentric rearrangements
involving chromosomes other than chromosome 21
can be detected by amniocentesis performed because
of advanced maternal age (Case 2) or fetal anomalies,
especially HPE (Cases 1 and 2). Balanced acrocentric
rearrangements involving chromosomes other than
chromosome 21 may also be detected by amniocente-
sis performed for advanced maternal age (Cases 3–8,
13, 14, 16, 19 and 21–23), abnormal maternal serum
screening results (Cases 10–12, 17, 20-1), maternal
carrier status (Cases 13, 16-2 and 16-3), paternal car-
rier status (Cases 5 and 20-2), abnormal ultrasound
findings (Case 9), or an elective cause (Case 15).
In our study, neither UPD14 nor UPD15 was
detected among 16 cases tested for UPD. The risk of
UPD in offspring of non-homologous Robertsonian
translocation carriers has been shown to be low but
not negligible. In a meta-analysis of 477 cases of prena-
tally detected non-homologous Robertsonian translo-
cations, Shaffer [11] found only three cases (0.63%)
with UPD. The author also found no significant differ-
ence in the frequency of UPD among the groups of
paternally derived, maternally derived and de novo non-
homologous Robertsonian translocations. Shaffer [11]
suggested that families carrying a fetus with a non-
homologous Robertsonian translocation may be advised
that the risk of UPD is less than 1% (about 0.6–0.8%).
Gualandi et al [12] found no UPD among 23 fetuses
with balanced Robertsonian translocations and sum-
marized an additional 55 cases with no UPD. Jay et al
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Figure 1. A case of rea(13q13q) trisomy 13 with a 46,XX,i(13)(q10) karyotype. There is one free chromosome 13 and one
isochromosome 13 (arrow).
Figure 2. A case of heterologous Robertsonian translocation trisomy 13 with a 46,XX, +13,der(13;14)(q10;q10) karyotype.
There are two free chromosomes 13, one free chromosome 14, and one derivative chromosome der(13;14) (arrow) containing
one translocated chromosome 13q and one translocated chromosome 14q.
1 2 3 4 5
6 7 8 9 10 11 12
13
19 20 21 22
14 15 16 17 18der(13;14)
Y X
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Figure 3. A case of balanced heterologous Robertsonian translocation rob(13q14q) carrier with a 45,XX,der(13;14)(q10;q10)
karyotype. There is one free chromosome 13, one free chromosome 14, and one derivative chromosome der(13;14) (arrow)
containing one translocated chromosome 13q and one translocated chromosome 14q.
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13 der(13;14) 14 15 16 17 18
19 20 21 22 Y X
1
6 7 8 9 10
2 3 4 5
11 12
13 14
der(14;15)
15 16 17 18
19 20 21 22 Y X
Figure 4. A case of balanced heterologous Robertsonian translocation rob(14q15q) carrier with a 45,XX,der(14;15)(q10;q10)
karyotype. There is one free chromosome 14, one free chromosome 15, and one derivative chromosome der(14;15) (arrow)
containing one translocated chromosome 14q and one translocated chromosome 15q.
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Figure 6. A case of balanced heterologous Robertsonian translocation rob(15q22q) carrier with a 45,XY,der(15;22)(q10;q10)
karyotype. There is one free chromosome 15, one free chromosome 22, and one derivative chromosome der(15;22) (arrow)
containing one translocated chromosome 15q and one translocated chromosome 22q.
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Figure 5. A case of balanced heterologous Robertsonian translocation rob(13q15q) carrier with a dicentric chromosome and
a 45,XX,dic(13;15)(p11.2;p11.2) karyotype. There is one free chromosome 13, one free chromosome 15, and one dicentric
chromosome dic(13;15) (arrow) containing one translocated chromosome 13 (13p11.2qter) and one translocated chromo-
some 15 (15p11.2qter).
[13] investigated 22 cases of balanced Robertsonian
translocations and found no UPD. Silverstein et al [14]
studied 42 fetuses with non-homologous Robertsonian
translocations and found one fetus with rob(13q14q)
and maternal isodisomy of chromosome 14. They
summarized an additional 273 cases from Berend et al
[15], Gualandi et al [12] and Jay et al [13], and con-
cluded that the risk of UPD was 0.63% (2/315; 95%
confidence interval, 0.2–2.3%) in prenatally diagnosed
non-homologous Robertsonian translocations. Sensi 
et al [16] studied 160 fetuses with non-homologous
Robertsonian translocations and found one case of
upd(14)mat with a 45,XX,der(14;22)(q10;q10)mat
karyotype. They summarized an additional 243 cases
from Eggermann et al [17], Berend et al [15], Silverstein
et al [14] and their additional cases, and concluded
that the risk of UPD was 0.74% (3/403; 95% confi-
dence interval, 0.17–2.34%) in prenatally diagnosed
non-homologous Robertsonian translocations. In a
study of 65 fetuses carrying familial and de novo non-
homologous Robertsonian translocations involving
chromosomes 14 and/or 15, and 18 fetuses who were
conceived by a Robertsonian translocation carrier parent
and had a normal karyotype, Ruggeri et al [18] found
one case of upd(14)mat with de novo rob(14q21q).
We found a de novo case of trisomy 13 with an
i(13q) of maternal origin (Case 1). This case had no
recurrence of trisomy 13 in two subsequent pregnan-
cies. Hassold et al [19] reported one de novo case of
rea(13q13q) trisomy 13 with an i(13q) of paternal ori-
gin. Shaffer et al [20] studied four de novo cases of
rea(13q13q) trisomy 13 and found that all were dicen-
tric, two were i(13q) of maternal origin, one was
i(13q) of paternal origin, and one was rob(13q13q) of
maternal origin. Robinson et al [21] reported two 
de novo cases of rea(13q13q) trisomy 13, both of which
were i(13q) of maternal origin. Bugge et al [3] studied
six de novo cases of rea(13q13q) of trisomy 13, and
found one i(13q) case of maternal origin, four i(13q)
cases of paternal origin, and one rob(13q13q) case of
maternal origin. Of the 14 cases of de novo rea(13q13q)
reported in the literature, two were rob(13q13q) of
maternal origin, six were i(13q) of maternal origin,
and six were i(13q) of paternal origin. In view of the
equal number (6:6) of maternal- and paternal-derived
cases of i(13q), Bugge et al [3] suggested that the
majority of cases of trisomy 13 due to rea(13q13q)
were i(13q) caused by postzygotic events. As for the
two rob(13q13q) trisomy 13 cases, the maternal origin
of rob(13q13q) may have arisen during oogenesis.
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Figure 7. A case of mosaic balanced heterologous Robertsonian translocation rob(14q22q) carrier with a 45,XY,der(14;22)
(q10;q10)/46,XY karyotype. The 45,XY,der(14;22)(q10;q10) karyotype shows one free chromosome 14, one free chromosome
22, and one derivative chromosome der(14;22) (arrow) containing one translocated chromosome 14q and one translocated
chromosome 22q.
In our study, we detected only one unbalanced
rearrangement (Case 2 with translocation trisomy 13)
among 19 fetuses from 16 families with an inherited
Robertsonian translocation. In a study of 230 cases of
amniocentesis performed because of rob(13q14q)
carrier mothers (157 cases) or rob(13q14q) fathers
(73 cases), Boué and Gallano [22] found no unbal-
anced results. In a study of 204 cases who underwent
prenatal diagnosis because of the presence of parental
carriers of a balanced rob(13q14q) translocation,
Daniel et al [23] found one case of translocation 
trisomy 13 among 136 carrier mothers and two cases of
translocation trisomy 13 among 68 carrier fathers. In
their study, the rate of translocation trisomy 13 to
female or male carriers of Robertsonian (13;14) trans-
location was 1–2%. Robinson et al [21] reported an
interesting translocation trisomy 13 case in which the
extra chromosome 13 was derived from a maternal mei-
otic event and the derivative chromosome rob(13q14q)
was inherited from the father. Since there is no signifi-
cantly increased risk of unbalanced offspring for a
rob(13q14q) carrier and because most trisomies are
maternal in origin, Robinson et al [21] believed this
interesting case was not surprising. In a study of 15 cases
of amniocentesis performed because of rob(13q15q)
carrier parents, Boué and Gallano [22] found no
unbalanced results, and Daniel et al [23] also found
no unbalanced results in a study of 16 cases of amnio-
centesis performed because of rob(13q15q) carrier
parents. In a study of 31 cases of amniocentesis per-
formed because of rob(13q21q) carrier mothers (20
cases) or rob(13q21q) carrier fathers (11 cases), Boué
and Gallano [22] found two translocation trisomy 21
fetuses, all in carrier mothers. In a study of 23 cases of
amniocentesis performed because of rob(13q21q)
carrier mothers (14 cases) or rob(13q21q) carrier
fathers (nine cases), Daniel et al [23] found two translo-
cation trisomy 21 fetuses, also all in carrier mothers.
They suggested that there was a 10–15% rate of unbal-
anced translocation trisomy 21 progeny for female
carriers of Robertsonian (D group chromosome;21)
translocations, while the rate was 2–5% for males.
However, the risk of having a child with translocation tri-
somy 13 or UPD for rob(13q14q), rob(13q15q),
rob(13q21q) and rob(13q22q) carriers is low. For
rob(13q14q), rob(13q15q), rob(13q21q) and rob
(13q22q) carriers, Gardner and Sutherland [5] sug-
gested a risk of ≤ 1% for translocation trisomy 13 and
< 0.5% risk for UPD14 and/or UPD15.
Both of our two cases with trisomy 13 caused by
unbalanced acrocentric rearrangements manifested
HPE on prenatal ultrasound. The phenotypic features
of unbalanced translocation trisomy 13 or rea(13q13q)
trisomy 13 are basically the same as those of free tri-
somy 13. Fetuses with translocation trisomy 13 or
rea(13q13q) trisomy 13 may predominantly present
with HPE on prenatal ultrasound, since HPE is associ-
ated with as many as 70% of trisomy 13 cases [24–26].
Prenatal sonographic detection of HPE should prompt
cytogenetic investigations that may lead to the identifi-
cation of an unexpected parental Robertsonian translo-
cation involving chromosome 13.
In conclusion, we have presented the results of 
prenatal diagnostic examinations for unbalanced and
balanced acrocentric rearrangements involving chro-
mosomes other than chromosome 21, using amnio-
centesis, parental cytogenetic analysis, and UPD
investigation. We suggest that prenatal diagnosis of
acrocentric rearrangements should include cytogenetic
analysis of the parents and UPD testing for cases
involving chromosomes 14 and 15.
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